Intravenous Versus Intracoronary Use of Abciximab

NCT00685464 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

355

Enrollment

OTHER

Sponsor class

Conditions

Atherosclerosis
Ischemic Heart Disease

Interventions

DRUG: Abciximab
DRUG: Abciximab

Sponsor

University Hospital, Gentofte, Copenhagen